Search Results

Avanir is developing its future leadership from within through a program it calls “Leading at Avanir,” which focuses on emotional intelligence and situational leadership components.

The November layoffs are the second known workforce reduction this year for Marinus Pharmaceuticals, which previously announced disappointing Phase III results for ganaxolone in two clinical trials.

Avanir Pharmaceuticals, Inc., a pharmaceutical company committed to delivering innovative central nervous system (CNS) solutions, today announced its recognition as one of the 2020 Best Places to Work in Orange County—the only pharmaceutical company listed in the Orange County Business Journal’s 2020 “Best Places to Work in Orange County” Large Employer Category.

Avanir Pharmaceuticals, Inc. and The UCI Paul Merage School of Business are pleased to announce the appointment of two new executives to the School’s Center for Health Care Management and Policy advisory board. Wa’el Hashad, president and CEO of Avanir Pharmaceuticals,

Avanir Pharmaceuticals, Inc. announced that it has reached a resolution of civil, criminal, and administrative claims with the federal government and participating state authorities.

Fennec Pharmaceuticals Inc., a commercial stage specialty pharmaceutical company, announced that Adrian Haigh has departed from his position as Fennec’s Chief Operating Officer as of June 30, 2024.

Deciphera Pharmaceuticals, Inc. today announced that it has entered into a definitive merger agreement with ONO Pharmaceutical Co., Ltd.

Aurorium, a specialty ingredients manufacturer and materials innovation partner, is pleased to announce the launch of Haelium™ Pharmaceutical Solutions.